APA (7th ed.) Citation

Nolan, S., Weldon, S., Cregan, R., Elnazir, B., Williamson, M., Cox, D., . . . Taggart, C. (2025). WS10.02Proteomic analysis of nasal lavage fluid and sputum samples in people with cystic fibrosis during 24 months of treatment with elexecaftor/tezacaftor/ivacaftor - The RECOVER study. Journal of Cystic Fibrosis, 24, S20. https://doi.org/10.1016/j.jcf.2025.03.547

Chicago Style (17th ed.) Citation

Nolan, S., et al. "WS10.02Proteomic Analysis of Nasal Lavage Fluid and Sputum Samples in People with Cystic Fibrosis During 24 Months of Treatment with Elexecaftor/tezacaftor/ivacaftor - The RECOVER Study." Journal of Cystic Fibrosis 24 (2025): S20. https://doi.org/10.1016/j.jcf.2025.03.547.

MLA (9th ed.) Citation

Nolan, S., et al. "WS10.02Proteomic Analysis of Nasal Lavage Fluid and Sputum Samples in People with Cystic Fibrosis During 24 Months of Treatment with Elexecaftor/tezacaftor/ivacaftor - The RECOVER Study." Journal of Cystic Fibrosis, vol. 24, 2025, p. S20, https://doi.org/10.1016/j.jcf.2025.03.547.